Skip to main content
Glama

get_device_clearances

Read-only

FDA 510(k) device clearance history from OpenFDA by device name. Returns K numbers, applicants, decisions, and receipt dates. Use for medtech competitive intelligence, regulatory pathway research, and supplier qualification. Source: FDA 510(k) database. $0.10 standard. Cryptographically attested with a post-quantum signed settlement receipt. Verify at trust.stratalize.com/verify.

Tool call template

Replace each placeholder with a value matching the input schema. Only required parameters are included; add optional parameters as needed.

{
  "id": 1,
  "jsonrpc": "2.0",
  "method": "tools/call",
  "params": {
    "arguments": {
      "device_name": "<device_name>"
    },
    "name": "get_device_clearances"
  }
}

Input Schema

NameRequiredDescriptionDefault
device_nameYes

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A3.9/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true and destructiveHint=false, so the safety profile is covered. The description adds value beyond them by disclosing the upstream source (FDA 510(k) database), the per-call cost ($0.10 standard), and an attestation/verification mechanism. It does not say anything about result caps or pagination, which is the main remaining behavioral gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The first two sentences are efficiently front-loaded with purpose, source and return fields. The closing sentences on pricing, post-quantum signed settlement receipts, and the verify URL are promotional and only marginally relevant to deciding whether and how to call the tool, diluting an otherwise tight definition.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With one parameter and no output schema, enumerating the returned fields is genuinely necessary and done well. However, an agent still cannot tell how many results come back, whether results are paged or limited, or how loosely device_name is matched, which matters for a search-style open-world call.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0% for the single required parameter, but the phrase 'by device name' does communicate what the parameter is for. It adds no detail on matching behavior (exact vs substring, brand vs generic names) or the 2-200 character constraint, so it partially but not fully compensates for the empty schema annotations.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource: retrieves FDA 510(k) device clearance history from OpenFDA, keyed by device name, and names the fields returned (K numbers, applicants, decisions, receipt dates). That is concrete enough to separate it from the many other single-dataset sibling tools without opening any schema.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives explicit use cases (medtech competitive intelligence, regulatory pathway research, supplier qualification), which tells an agent the domain where this tool is the right call. It stops short of naming when NOT to use it or pointing to an alternative tool for adjacent questions, so it is clear context rather than full routing guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources